L. Garland

发表

The absolute bioavailability of oral vinorelbine in patients with solid tumors

D. Sullivan, R. Lush, J. McCune, 2005, Cancer Chemotherapy and Pharmacology.

Effects of Black and Green Tea Consumption on Blood Pressure and Liver Enzymes: A Randomized Controlled Trial

Robin B Harris, L. Garland, I. Hakim, 2018 .

D. Alberts, J. Ranger-Moore, P. Thompson, 2004 .

Phase II Study of Cediranib in Patients with Malignant Pleural Mesothelioma: SWOG S0509

A. Wozniak, D. Gandara, A. Tsao, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

18F-FDG PET/CT Can Predict Development of Thyroiditis Due to Immunotherapy for Lung Cancer

E. Krupinski, P. Kuo, L. Garland, 2018, The Journal of Nuclear Medicine Technology.

A Phase I Clinical and Pharmacokinetic Study of Oral CI-1033 in Combination with Docetaxel in Patients with Advanced Solid Tumors

M. Hidalgo, D. Ryan, B. Arun, 2006, Clinical Cancer Research.

APhase I Clinical and Pharmacokinetic Study of Oral CI-1033 in Combinationwith Docetaxel in Patients with Advanced Solid Tumors

M. Hidalgo, D. Ryan, B. Arun, 2006 .

SWOG S0722: Phase II Study of mTOR Inhibitor Everolimus (RAD001) in Advanced Malignant Pleural Mesothelioma (MPM)

S. Ou, D. Gandara, J. Testa, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

A Phase I Pharmacokinetic Study of HMN-214, a Novel Oral Stilbene Derivative with Polo-Like Kinase-1–Interacting Properties, in Patients with Advanced Solid Tumors

D. V. Von Hoff, L. Garland, Charles Taylor, 2006, Clinical Cancer Research.

High activity of the anti-IGF-IR antibody CP-751,871 in combination with paclitaxel and carboplatin in squamous NSCLC

S. Novello, L. Paz-Ares, C. Langer, 2008 .

Selenium Supplementation and Lung Cancer Incidence

B. Turnbull, L. Clark, J. Marshall, 2002 .

Selenium supplementation and lung cancer incidence: an update of the nutritional prevention of cancer trial.

B. Turnbull, L. Clark, J. Marshall, 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Using logistic regression to improve the prognostic value of microarray gene expression data sets: application to early-stage squamous cell carcinoma of the lung and triple negative breast carcinoma

D. Mount, Ann M Manziello, Jesse D. Martinez, 2014, BMC Medical Genomics.

Phase II study of erlotinib in patients with malignant pleural mesothelioma: a Southwest Oncology Group Study.

A. Klein-Szanto, D. Gandara, J. Testa, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical Study of Aspirin and Zileuton on Biomarkers of Tobacco-Related Carcinogenesis in Current Smokers

Gang Liu, E. Szabo, A. Spira, 2022, Cancers.

A Practical Guide of the Southwest Oncology Group to Measure Malignant Pleural Mesothelioma Tumors by RECIST and Modified RECIST Criteria

D. Gandara, A. Tsao, L. Garland, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

SWOG S0509: A phase II study of novel oral antiangiogenic agent AZD2171 (NSC-732208) in malignant pleural mesothelioma.

A. Wozniak, D. Gandara, A. Tsao, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Lung Cancer Prevention

L. Garland, I. Hakim, 2014 .

Gender Difference in Systemic Oxidative Stress and Antioxidant Capacity in Current and Former Heavy Smokers

Robin B Harris, L. Garland, I. Hakim, 2012, Cancer Epidemiology, Biomarkers & Prevention.

Reply to the Letter to the Editor Entitled A Practical Guide to Measure “All” Malignant Pleural Mesothelioma Tumors by Modified RECIST Criteria?

D. Gandara, A. Tsao, L. Garland, 2011 .

Incidence of Brain Metastases on Follow-up 18F-FDG PET/CT Scans of Non–Small Cell Lung Cancer Patients: Should We Include the Brain?

R. Avery, P. Kuo, L. Garland, 2017, The Journal of Nuclear Medicine Technology.

Individualizing mesothelioma treatment: small steps into a brighter future.

A. Tsao, R. Flores, L. Garland, 2010, Clinical lung cancer.

Safety, Pharmacokinetics, and Pharmacodynamics of the Insulin-Like Growth Factor Type 1 Receptor Inhibitor Figitumumab (CP-751,871) in Combination with Paclitaxel and Carboplatin

L. Paz-Ares, C. Langer, L. Terstappen, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Chemotherapy for Malignant Pleural Mesothelioma

L. Garland, 2011, Current treatment options in oncology.

Randomized Crossover Trial Evaluating Detoxification of Tobacco Carcinogens by Broccoli Seed and Sprout Extract in Current Smokers

M. Padi, E. Szabo, J. Bauman, 2022, Cancers.

Developing an ACT-based intervention to address lung cancer stigma: Stakeholder recommendations and feasibility testing in two NCI-designated cancer centers

Deanna M. Kaplan, J. Ostroff, Timothy J. Williamson, 2022, Journal of psychosocial oncology.

Carfilzomib combined with suberanilohydroxamic acid (SAHA) synergistically promotes endoplasmic reticulum stress in non-small cell lung cancer cell lines

A. Baker, L. Garland, Neale T. Hanke, 2016, Journal of Cancer Research and Clinical Oncology.

Molecular correlates of the EGFR signaling pathway in association with SWOG S0218: a phase II study of oral EGFR tyrosine kinase inhibitor OSI-774 (NSC-718781) in patients with malignant pleural mesothelioma (MPM).

D. Gandara, C. Rankin, E. Borden, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Resveratrol Modulates Drug- and Carcinogen-Metabolizing Enzymes in a Healthy Volunteer Study

Jessica A. Miller, Chiu-Hsieh Hsu, D. Alberts, 2010, Cancer Prevention Research.

Modulates Drug-and Carcinogen-Metabolizing Pr R ymes in a Healthy Volunteer Study

Chiu-Hsieh Hsu, D. Alberts, J. Crowell, 2010 .

Multiple myeloma in women with silicone breast implants. Serum immunoglobulin and interleukin-6 studies in women at risk.

L. Moscinski, L. Garland, K. Benson, 1996, Current topics in microbiology and immunology.

The National Cancer Institute Silicone Implant/Multiple Myeloma Registry.

G. Tricot, M. Potter, L. Garland, 1996, Current topics in microbiology and immunology.

A pilot clinical study of resveratrol in postmenopausal women with high body mass index: effects on systemic sex steroid hormones

Chiu-Hsieh Hsu, T. Cornelison, L. Garland, 2014, Journal of Translational Medicine.

O-187 Efficacy and safety of single agent pertuzumab (rhuMAb 2C4), a HER dimerization inhibitor, in Non-Small Cell Lung Cancer (NSCLC) patients after prior chemotherapy

T. Dang, R. Herbst, V. Miller, 2005 .

Phase I study of BMS-599626, an oral pan-HER tyrosine kinase inhibitor, in patients with advanced solid tumors

R. Martell, M. Pegram, M. Gordon, 2005 .

A phase I clinical and pharmacokinetic (PK) study of oral CI-1033 + docetaxel (DOC) in the treatment of patients with advanced solid tumors

M. Hidalgo, B. Arun, P. Lenehan, 2005 .

Continued high activity of figitumumab (CP-751,871) combination therapy in squamous lung cancer.

S. Novello, M. Dolled-Filhart, L. Paz-Ares, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

APhase I Pharmacokinetic Study of HMN-214, a Novel Oral Stilbene Derivativewith Polo-Like Kinase-1^ Interacting Properties, in Patients with Advanced SolidTumors

L. Garland, D. D. Hoff, D. Pilkington, 2006 .

Efficacy of the anti-insulin like growth factor I receptor (IGF-IR) antibody CP-751871 in combination with paclitaxel and carboplatin as first-line treatment for advanced non-small cell lung cancer (NSCLC)

L. Paz-Ares, C. Langer, A. Gualberto, 2007 .

Regional Changes in Brain 18F-FDG Uptake After Prophylactic Cranial Irradiation and Chemotherapy in Small Cell Lung Cancer May Reflect Functional Changes

E. Krupinski, R. Hamilton, P. Kuo, 2018, The Journal of Nuclear Medicine Technology.

Double-negative (CD27−IgD−) B cells are expanded in NSCLC and inversely correlate with affinity-matured B cell populations

Jesse D. Martinez, C. Putnam, L. Garland, 2018, Journal of Translational Medicine.

Coping with COVID-19 in Patients with Lung Cancer

H. Hamann, L. Garland, Elizabeth S Ver Hoeve, 2022, Oncology Issues.

Efficacy and Safety of Single-Agent Pertuzumab, a Human Epidermal Receptor Dimerization Inhibitor, in Patients with Non–Small Cell Lung Cancer

A. D. Van den Abbeele, T. Dang, R. Herbst, 2007, Clinical Cancer Research.

Effect of Intermittent Versus Continuous Low-Dose Aspirin on Nasal Epithelium Gene Expression in Current Smokers: A Randomized, Double-Blinded Trial

Chiu-Hsieh Hsu, D. Alberts, Xiaohui Zhang, 2019, Cancer Prevention Research.

Phase I Trial of Intravenous IL-4 Pseudomonas Exotoxin Protein (NBI-3001) in Patients with Advanced Solid Tumors That Express the IL-4 Receptor

R. Puri, D. V. Von Hoff, L. Garland, 2005, Journal of immunotherapy.

DNA methylation biomarkers discovered in silico detect cancer in liquid biopsies from non-small cell lung cancer patients

D. Mahadevan, L. Vrba, B. Futscher, 2019, Epigenetics.

Comparative efficacy and safety of immunotherapies targeting the PD-1/PD-L1 pathway for previously treated advanced non-small cell lung cancer: A Bayesian network meta-analysis.

I. Abraham, Jennifer R Martin, L. Garland, 2019, Critical reviews in oncology/hematology.

Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer.

Joe Y. Chang, Edward S. Kim, P. Brown, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Is There a Role for Cancer-Directed Surgery in Early-Stage Sarcomatoid or Biphasic Mesothelioma?

D. Bull, L. Garland, Z. Khalpey, 2019, The Annals of thoracic surgery.

Can stereotactic fractionated radiation therapy become the standard of care for early stage non-small cell lung carcinoma.

Russ Hamilton, Vincent Vinh-Hung, Linda Garland, 2008, Cancer treatment reviews.

Molecular Analysis of Non–Small Cell Lung Cancer Identifies Subsets with Different Sensitivity to Insulin-like Growth Factor I Receptor Inhibition

Adrian V. Lee, S. McDonald, D. Rimm, 2010, Clinical Cancer Research.

A Dose-finding Study Followed by a Phase II Randomized, Placebo-controlled Trial of Chemoradiotherapy With or Without Veliparib in Stage III Non-small-cell Lung Cancer: SWOG 1206 (8811).

S. Gettinger, K. Kelly, D. Gandara, 2021, Clinical lung cancer.

A Phase I and pharmacokinetic study of HMN-214, a novel oral polo-like kinase inhibitor, in patients with advanced solid tumors.

D. V. Von Hoff, C. Taylor, L. Garland, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Abstract CT089: Phase Ib/II of CD40 agonistic antibody APX005M in combination with nivolumab (nivo) in subjects with metastatic melanoma (M) or non-small cell lung cancer (NSCLC)

G. Linette, Melissa L. Johnson, M. Edelman, 2019, Clinical Trials.

Interactive Sensor-Based Balance Training in Older Cancer Patients with Chemotherapy-Induced Peripheral Neuropathy: A Randomized Controlled Trial

Michael Schwenk, Bijan Najafi, Amy E. Muchna, 2015, Gerontology.

Diffusion Tensor Imaging of the Ankle as a Possible Predictor of Chemotherapy Induced Peripheral Neuropathy: Pilot Study.

E. Krupinski, B. Najafi, M. Schwenk, 2019, Current problems in diagnostic radiology.

Relationship of hemoglobin levels to fatigue and cognitive functioning among cancer patients receiving chemotherapy.

P. Jacobsen, L. Garland, E. Grendys, 2004, Journal of pain and symptom management.

Pilot Study: Texture Analysis of PET Imaging Demonstrates Changes in 18F-FDG Uptake of the Brain After Prophylactic Cranial Irradiation

David M Sawyer, R. Hamilton, P. Kuo, 2020, The Journal of Nuclear Medicine Technology.

Carfilzomib demonstrates broad anti-tumor activity in pre-clinical non-small cell and small cell lung cancer models

Amanda F Baker, A. Baker, L. Garland, 2014, Journal of experimental & clinical cancer research : CR.

Phase II study of the anti-insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer.

S. Novello, L. Paz-Ares, C. Langer, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Using logistic regression to improve the prognostic value of microarray gene expression data sets: application to early-stage squamous cell carcinoma of the lung and triple negative breast carcinoma

D. Mount, Ann M Manziello, Jesse D. Martinez, 2014, BMC Medical Genomics.

SWOG 0722: A phase II study of mTOR inhibitor everolimus (RAD001) in malignant pleural mesothelioma (MPM).

S. Ou, A. Wozniak, D. Gandara, 2012 .

Characterization of carfilzomib-resistant non-small cell lung cancer cell lines

B. Seligmann, A. Baker, M. Marron, 2018, Journal of Cancer Research and Clinical Oncology.

A pilot clinical study of resveratrol in postmenopausal women with high body mass index: effects on systemic sex steroid hormones

Chiu-Hsieh Hsu, T. Cornelison, L. Garland, 2014, Journal of Translational Medicine.

Effect of Intermittent Versus Continuous Low-Dose Aspirin on Nasal Epithelium Gene Expression in Current Smokers: A Randomized, Double-Blinded Trial

Chiu-Hsieh Hsu, D. Alberts, Xiaohui Zhang, 2019, Cancer Prevention Research.

Phase II study of erlotinib with concurrent whole-brain radiation therapy for patients with brain metastases from non-small cell lung cancer.

J. Welsh, A. Amini, B. Stea, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

C. Rankin, R. Nagle, L. Garland, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

18F-FDG PET/CT Can Predict Development of Thyroiditis Due to Immunotherapy for Lung Cancer

E. Krupinski, P. Kuo, L. Garland, 2018, The Journal of Nuclear Medicine Technology.

Can stereotactic fractionated radiation therapy become the standard of care for early stage non-small cell lung carcinoma.

J. Welsh, V. Vinh-Hung, N. Nguyen, 2008, Cancer treatment reviews.

Regional Changes in Brain 18F-FDG Uptake After Prophylactic Cranial Irradiation and Chemotherapy in Small Cell Lung Cancer May Reflect Functional Changes

E. Krupinski, R. Hamilton, P. Kuo, 2018, The Journal of Nuclear Medicine Technology.